Clinial Case Study
SSRI-induced sexual dysfunction treated with sildenafil
Sanjay Gupta M.D.,
Thomas Droney R.N.,
Prakash Masand M.D.,
Adam K. Ashton M.D.,
Corresponding Author
Sanjay Gupta M.D.
SUNY Health Science Center at Syracuse, Syracuse, New York
University of Buffalo, Buffalo, New York
Olean General Hospital, Olean, New York
Research and Education Division of Psychiatric Network, Olean General Hospital West, 2221 West State Street, Olean, NY 14760Search for more papers by this authorThomas Droney R.N.
Cattaraugus County Day Treatment Program, Olean, New York
Search for more papers by this authorPrakash Masand M.D.
SUNY Health Science Center at Syracuse, Syracuse, New York
Search for more papers by this authorSanjay Gupta M.D.,
Thomas Droney R.N.,
Prakash Masand M.D.,
Adam K. Ashton M.D.,
Corresponding Author
Sanjay Gupta M.D.
SUNY Health Science Center at Syracuse, Syracuse, New York
University of Buffalo, Buffalo, New York
Olean General Hospital, Olean, New York
Research and Education Division of Psychiatric Network, Olean General Hospital West, 2221 West State Street, Olean, NY 14760Search for more papers by this authorThomas Droney R.N.
Cattaraugus County Day Treatment Program, Olean, New York
Search for more papers by this authorPrakash Masand M.D.
SUNY Health Science Center at Syracuse, Syracuse, New York
Search for more papers by this authorFirst published: 21 June 1999
Citations: 11
Abstract
This report describes the presence of sexual dysfunction associated with selective serotonin reuptake inhibitors (SSRIs) in two male patients treated successfully with sildenafil (Viagra). The sexual dysfunction was assessed using the Arizona Sexual Experiences Scale for males (ASEX-Males; McGahuey et al. [1997: Presented at the 150th Annual Meeting of the American Psychiatric Association, May 19, 1997, San Diego, CA]). Depression and Anxiety 9:180–182, 1999.© 1999 Wiley-Liss, Inc.
REFERENCES
- Ashton AK, Hamer R, Rosen RC. 1997. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Mar Ther 23: 165–175.
- Balogh S, Hendricks S, Kang J. 1992. Treatment of fluoxetine-induced anorgasmia with amantadine. J Clin Psychiatry 53: 212–213.
- Bartlik BD, Kaplan P, Kaplan HS. 1995. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin reuptake inhibitors. J Sex Mar Ther 21: 264–271.
- Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. 1996. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 78: 257–261.
- Chuang AT, Strauss JD, Murphy RA, Steers WD. 1998. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 160: 257–261.
- Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. 1998. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338: 1397–1404.
- Grimsley SR, Jann MW. 1992. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm 11: 930–957.
- Gupta S, Masand PS, Ashton AK, Berry SL. 1999. Phenelzine-induced sexual dysfunction treated with sildenafil. J Sex Mar Ther 25: 131–135.
- Harrison WM, Rabkin JG, Ehrhardt AA, Stewart JW, McGrath PJ, Ross D, Quitkin RM. 1986. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 6: 144–149.
- Harvey KV, Balon R. 1995. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 7: 189–201.
- Jacobsen FM. 1992. Fluoxetine-associated sexual dysfunction and an open trial of treatment of yohimbine. J Clin Psychiatry 53: 119–122.
- Labbate LA, Pollack MH. 1994. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry 6: 13–15.
- Lesko LM, Stotland NL, Seagraves RT. 1982. Three cases of female anorgasmia with MAOIs. Am J Psychiatry 139: 1353–1354.
- Masand PS, Reddy N, Gregory RJ. 1995. SSRI-induced sexual dysfunction successfully treated with amantadine. Depression 2: 31–321.
- McGahuey CA, Gelenberg AJ, Laukes C, Manber R, McKnight K, Moreno FA, Delgado PL. 1997. The Arizona Sexual Experiences Scale (ASEX): validity and reliability. Presented at the 150th Annual Meeting of the American Psychiatric Association, May 19, 1997, San Diego, CA.
- Michelson D, Bancroft J, Targum S, Tollefson G. 1998. Buspirone and amantadine treatment of SSRI associated sexual dysfunction: a randomized, placebo-controlled trial (abstract). Presented at the 37th Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 1–18, 1998.
- Mitchell JE, Popkin MK. 1983. Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 3: 76–79.
- Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. 1987. Anorgasmiform clomipramine in obsessive compulsive disorder: a controlled trial. Br J Psychiatry 151: 107–112.
- Nelson EB, Keck PE, McElroy SL. 1997. Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron (letter). J Clin Psychiatry 58: 496–497.
- Patterson WM. 1993. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 54: 71.
- Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J. 1990. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51 (suppl B): 18–27.
- Segraves RT. 1982. Male sexual dysfunction and psychoactive drug use: review of a common relationship. Postgrad Med 71: 227–233.
- Segraves RT. 1994. Treatment of drug-induced anorgasmia. Br J Psychiatry 165: 554.
- Shen WW, Park S. 1983. The use of monoamine oxidase inhibitors in the treatment of traumatic war neurosis: a case report. Milit Med 148: 430–431.
